Swift Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Swift Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10603
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company’s products include 2S hyb DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA library kit, comprehensive TP53 panel, 56G oncology panel, EGFR pathway panel and sample ID panel, among others. It develops technologies to examine disease-related genes, improve next generation sequencing sample preparation for illumina and ion torrent platforms, and accelerate sample preparation for DNA sequencing and deliver more usable data from next gen sequencing instruments. The company’s products finds application in circulating cell free DNA and tumor cells, amplicon sequencing, bisulfite sequencing, molecular identifiers, hybridization capture sequencing, whole genome sequencing, metagenomics, and others. Swift Biosciences is headquartered in Ann Arbor, Michigan, the US.

Swift Biosciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Swift Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Swift Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Swift Biosciences Raises USD12.2 Million in Venture Financing 11
Swift Biosciences Raises USD1.5 Million in Venture Financing 12
Swift Biosciences Raises US$7 Million In Series B Financing 13
Swift Biosciences Raises US$0.8 Million In Series A-1 Financing Round 14
Swift Biosciences Raises US$0.5 Million In Venture Financing 15
Partnerships 16
Horizon Discovery Enters into Agreement with Swift Biosciences 16
Swift Biosciences Inc – Key Competitors 17
Swift Biosciences Inc – Key Employees 18
Swift Biosciences Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Corporate Communications 20
May 23, 2018: Swift Biosciences Builds on Momentum, Accelerates Growth with Addition of Nathan Wood as New CEO 20
Jun 29, 2017: Swift Biosciences adds two new Directors to Board 21
Product News 22
Apr 06, 2018: Swift Biosciences Launches Unique Dual Indexing Kits to improve Multiplexed Next Generation Sequencing 22
Feb 14, 2017: Swift Biosciences Launches Novel Long-Insert Library Kit to Improve Data Quality on PacBio Sequencing Platforms 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Swift Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Swift Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Swift Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Swift Biosciences Raises USD12.2 Million in Venture Financing 11
Swift Biosciences Raises USD1.5 Million in Venture Financing 12
Swift Biosciences Raises US$7 Million In Series B Financing 13
Swift Biosciences Raises US$0.8 Million In Series A-1 Financing Round 14
Swift Biosciences Raises US$0.5 Million In Venture Financing 15
Horizon Discovery Enters into Agreement with Swift Biosciences 16
Swift Biosciences Inc, Key Competitors 17
Swift Biosciences Inc, Key Employees 18

List of Figures
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Swift Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Swift Biosciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Swift Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • American Overseas Group Limited:企業の戦略・SWOT・財務分析
    American Overseas Group Limited - Strategy, SWOT and Corporate Finance Report Summary American Overseas Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Wuhan Kaidi Electric Power Co Ltd (000939):電力:M&Aディール及び事業提携情報
    Summary Wuhan Kaidi Electric Power Co Ltd (Wuhan Kaidi) is a renewable energy company that offers power supply and new energies technology and services. The company produces biomass energy from forestry and agricultural residues. Its services include technical research and development, investment an …
  • Schindler Holding Ltd.:企業の戦略・SWOT・財務情報
    Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report Summary Schindler Holding Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • MModal IP LLC:企業の戦略的SWOT分析
    MModal IP LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Mercury Systems Inc (MRCY):企業の財務・戦略的SWOT分析
    Summary Mercury Systems Inc (Mercury) is a technology company that develops defense electronic solutions. It offers products such as chassis and subsystems, solid state drives, memory, mixed-signal processing, mission computing and avionics, system in package, high density secure memory, FPGA digita …
  • Molecular Templates Inc (MTEM):製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Templates Inc (MTI), formerly Threshold Pharmaceuticals Inc, is a clinical-stage oncology company that discovers and develops biologic therapeutics for cancer. The company’s pipeline products include MT-3724, MT-4019, MT-5111, MT-5050 and MT-6868. Its lead product MT-3724, a fusion …
  • s.a. D’leteren n.v.:企業の戦略・SWOT・財務情報
    s.a. D'leteren n.v. - Strategy, SWOT and Corporate Finance Report Summary s.a. D'leteren n.v. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Biogen Inc (BIIB):医療機器:M&Aディール及び事業提携情報
    Summary Biogen Inc (Biogen) is a global biopharmaceutical company that discovers, develops and delivers drugs for the treatment of neurological and neurodegenerative diseases worldwide. The company’s marketed products include Avonex (interferon beta-1a), Tysabri (natalizumab), Tecfidera (dimethyl fu …
  • Rexel S.A.:企業の戦略・SWOT・財務情報
    Rexel S.A. - Strategy, SWOT and Corporate Finance Report Summary Rexel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • AstraZeneca Plc (AZN):医療機器:M&Aディール及び事業提携情報
    Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and renal and metabolic diseases; and cancer, besides autoimmune, infection a …
  • Pascal Biosciences Inc (PAS):製薬・医療:M&Aディール及び事業提携情報
    Summary Pascal Biosciences Inc (Pascal Biosciences), formerly BioMmune Technologies Inc is a biotechnology company that discovers and develops treatments in the field of immuno-oncology. The company develops targeted agents that enable the body's own immune system to recognize and attack cancers, in …
  • Tata Chemicals Ltd (TATACHEM):企業の財務・戦略的SWOT分析
    Summary Tata Chemicals Ltd (TCL) operates as a chemical company engaged in offering industry, living, and farm essential chemicals. The company's products include dals, consumer salt, water purifier, soda ash, spices, sodium bicarbonate, allied chemicals, industrial salt, customized fertilizers, cem …
  • Constellation Brands, Inc.:戦略・SWOT・企業財務分析
    Constellation Brands, Inc. - Strategy, SWOT and Corporate Finance Report Summary Constellation Brands, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Unicaja Banco SA:企業の戦略・SWOT・財務分析
    Unicaja Banco SA - Strategy, SWOT and Corporate Finance Report Summary Unicaja Banco SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • New Wave Group AB (NEWA B):企業の財務・戦略的SWOT分析
    New Wave Group AB (NEWA B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Scorpio Tankers Inc (STNG):石油・ガス:M&Aディール及び事業提携情報
    Summary Scorpio Tankers Inc. (Scorpio Tankers), a part of Scorpio Group, provides marine transportation of refined petroleum products and crude oil worldwide. The company operates through a network of owned and time chartered vessels, which distribute vegetable oils, petroleum-based feedstock and re …
  • Geistlich Pharma AG:企業の戦略的SWOT分析
    Geistlich Pharma AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Edwards Lifesciences Corp (EW)-製薬・医療分野:企業M&A・提携分析
    Summary Edwards Lifesciences Corp (Edwards) is a global medical technology company, which focuses on the development, manufacture and marketing of products and technologies used for the treatment of structural heart disease and critical conditions. It develops and commercializes heart valve products …
  • Paoli Calmettes Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Paoli Calmettes Institute (IPC) is a cancer treatment institute. The institute provides medical activities such as consultations, imaging examinations, chemotherapy preparations, radiotherapy sessions, surgical stays, endoscopies, and bone marrow and stem cell transplants. Its areas of disti …
  • China Longyuan Power Group Corporation Ltd (916):電力:M&Aディール及び事業提携情報
    Summary China Longyuan Power Group Corporation Ltd (CLPGC), a subsidiary of China Energy Investment Corporation Ltd, carries out design, development, construction, management and operation of wind farms. It generates and sells electricity to the local grid companies. The company also operates other …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆